Rankings
▼
Calendar
AMPH Q3 2019 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMPH
Amphastar Pharmaceuticals, Inc.
$860M
Q3 2019 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$80M
+6.1% YoY
Gross Profit
$35M
44.0% margin
Operating Income
$2M
3.0% margin
Net Income
$1M
1.6% margin
EPS (Diluted)
$0.03
QoQ Revenue Growth
+1.4%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$21M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$586M
Total Liabilities
$152M
Stockholders' Equity
$389M
Cash & Equivalents
$86M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$80M
$76M
+6.1%
Gross Profit
$35M
$29M
+20.5%
Operating Income
$2M
$3M
-5.7%
Net Income
$1M
$2M
-45.2%
Revenue Segments
Active Pharmaceutical Ingredient Segment
$4M
100%
Geographic Segments
U
$76M
100%
C
$59,000
0%
← FY 2019
All Quarters
Q4 2019 →